Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Administration of AAV8-human Cocaine Hydrolase to Treat Cocaine Use Disorder

NCT04884594 is registered in ClinicalTrials.gov with W. Michael Hooten as lead sponsor.

NCT NCT04884594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04884594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Administration of AAV8-human Cocaine Hydrolase to Treat Cocaine Use Disorder
Lead sponsor
W. Michael Hooten
Phase
Phase 1
Overall status
Active, not recruiting
Start date
October 8, 2021
Completion date
December 31, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine dependence, in remission